Nagashima K - Search Results

1

Dynamic fluorescent imaging of human immunodeficiency virus type 1 gag in live cells by biarsenical labeling.

Rudner L, Nydegger S, Coren LV, Nagashima K, Thali M, Ott DE. Rudner L, et al. Among authors: nagashima k. J Virol. 2005 Apr;79(7):4055-65. doi: 10.1128/JVI.79.7.4055-4065.2005. J Virol. 2005. PMID: 15767407 Free PMC article.

2

Elimination of protease activity restores efficient virion production to a human immunodeficiency virus type 1 nucleocapsid deletion mutant.

Ott DE, Coren LV, Chertova EN, Gagliardi TD, Nagashima K, Sowder RC 2nd, Poon DT, Gorelick RJ. Ott DE, et al. Among authors: nagashima k. J Virol. 2003 May;77(10):5547-56. doi: 10.1128/jvi.77.10.5547-5556.2003. J Virol. 2003. PMID: 12719547 Free PMC article.

3

Heterologous late-domain sequences have various abilities to promote budding of human immunodeficiency virus type 1.

Ott DE, Coren LV, Gagliardi TD, Nagashima K. Ott DE, et al. Among authors: nagashima k. J Virol. 2005 Jul;79(14):9038-45. doi: 10.1128/jvi.79.14.9038-9045.2005. J Virol. 2005. PMID: 15994797 Free PMC article.

4

A PLPPV sequence in the p8 region of Gag provides late domain function for mouse mammary tumor virus.

Coren LV, Nagashima K, Ott DE. Coren LV, et al. Among authors: nagashima k. Virology. 2019 Sep;535:272-278. doi: 10.1016/j.virol.2019.07.015. Epub 2019 Jul 19. Virology. 2019. PMID: 31357166 Free PMC article.

5

Quantitation of HLA class II protein incorporated into human immunodeficiency type 1 virions purified by anti-CD45 immunoaffinity depletion of microvesicles.

Trubey CM, Chertova E, Coren LV, Hilburn JM, Hixson CV, Nagashima K, Lifson JD, Ott DE. Trubey CM, et al. Among authors: nagashima k. J Virol. 2003 Dec;77(23):12699-709. doi: 10.1128/jvi.77.23.12699-12709.2003. J Virol. 2003. PMID: 14610192 Free PMC article.

6

Proteomic and biochemical analysis of purified human immunodeficiency virus type 1 produced from infected monocyte-derived macrophages.

Chertova E, Chertov O, Coren LV, Roser JD, Trubey CM, Bess JW Jr, Sowder RC 2nd, Barsov E, Hood BL, Fisher RJ, Nagashima K, Conrads TP, Veenstra TD, Lifson JD, Ott DE. Chertova E, et al. Among authors: nagashima k. J Virol. 2006 Sep;80(18):9039-52. doi: 10.1128/JVI.01013-06. J Virol. 2006. PMID: 16940516 Free PMC article.

7

Real-time visualization of HIV-1 GAG trafficking in infected macrophages.

Gousset K, Ablan SD, Coren LV, Ono A, Soheilian F, Nagashima K, Ott DE, Freed EO. Gousset K, et al. Among authors: nagashima k. PLoS Pathog. 2008 Mar 7;4(3):e1000015. doi: 10.1371/journal.ppat.1000015. PLoS Pathog. 2008. PMID: 18369466 Free PMC article.

8

Equine infectious anemia virus and the ubiquitin-proteasome system.

Ott DE, Coren LV, Sowder RC 2nd, Adams J, Nagashima K, Schubert U. Ott DE, et al. Among authors: nagashima k. J Virol. 2002 Mar;76(6):3038-44. doi: 10.1128/jvi.76.6.3038-3044.2002. J Virol. 2002. PMID: 11861870 Free PMC article.

9

Basic residues in the nucleocapsid domain of Gag are critical for late events of HIV-1 budding.

Dussupt V, Sette P, Bello NF, Javid MP, Nagashima K, Bouamr F. Dussupt V, et al. Among authors: nagashima k. J Virol. 2011 Mar;85(5):2304-15. doi: 10.1128/JVI.01562-10. Epub 2010 Dec 15. J Virol. 2011. PMID: 21159863 Free PMC article.

10

Late assembly motifs of human T-cell leukemia virus type 1 and their relative roles in particle release.

Heidecker G, Lloyd PA, Fox K, Nagashima K, Derse D. Heidecker G, et al. Among authors: nagashima k. J Virol. 2004 Jun;78(12):6636-48. doi: 10.1128/JVI.78.12.6636-6648.2004. J Virol. 2004. PMID: 15163754 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,004 results

Search Page

Filters